This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction Atrialfibrillation is the most prevalent sustained arrhythmia worldwide and is expected to increase substantially within the coming years. Eligible patients are randomised 1:1 to either a combined supervised and eHealth-based exercise intervention or usual care for 12 months.
arrhythmia yield versus 69.1% in daily-symptom patients, demonstrating that greater symptom frequenc y does not necessarily reflect increased arrhythmia burden. arrhythmia yield versus 69.1% in daily-symptom patients, demonstrating that greater symptom frequenc y does not necessarily reflect increased arrhythmia burden.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. Food & Drug Administration ( FDA ). Int J Stroke.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
Patients who present with persistent atrialfibrillation at diagnosis are more likely to have certain riskfactors as compared with patients with occasional atrialfibrillation (AFib).
Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.
A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrialfibrillation (AF) is still reported.1 A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrialfibrillation (AF) is still reported.1
Atrialfibrillation (AF) is the most common arrhythmia in the U.S., Black Americans are less prone to develop AF than White Americans, but they display a higher burden of modifiable riskfactors for cardiovascular disease and higher rates of ischemic stroke.
Research Highlights: A clinical trial with adults who have atrialfibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.
Atrialfibrillation is the most prevalent sustained cardiac arrhythmia and an important riskfactor for ischemic stroke resulting in a fivefold increased stroke risk.
Atrialfibrillation (AF) prediction improves by combining clinical scores with a polygenic risk score (PRS) for AF (AF-PRS), but there are limited studies of PRS for ventricular arrhythmia (VA) prediction.
Risk stratification for atrialfibrillation (AF) and ventricular arrhythmia (VA) is suboptimal despite high cardiovascular (CV) comorbidity and mortality. AF has a strong genetic basis, but the genetic architecture of VA is less studied.
Asthma is a known riskfactor for atrialfibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 In: AF Symposium.;
Atrialfibrillation (AF) is the most prevalent arrhythmia in clinical practice, and obesity serves as a significant riskfactor for its development. The underlying mechanisms of obesity-related AF remain intri.
Abstract Background Postoperative atrialfibrillation (POAF) is the most frequent cardiac arrhythmia following cardiac operations. It has been associated with an increased risk of postoperative cerebrovascular complications, morbidity and mortality. At 1250-day follow-up, While the incidence of POAF was 2.9%
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. This increases the pressure inside your ear and chest, which reduces some heart arrhythmias. Maintain a Healthy Weight – Excess weight is a major riskfactor for AFib.
Background Atrialfibrillation (AF), a common, frequently asymptomatic cardiac arrhythmia, is a major riskfactor for stroke. Identification of AF enables effective preventive treatment to be offered, potentially reducing stroke risk by up to two-thirds.
Cardiac accumulation triggers local tissue injury, electrical instability and arrhythmia. Bradyarrhythmia and atrialfibrillation (AF) incidence are reported in up to 16% and 13%, respectively. per 1-year increase in age) and a riskfactor for PPM implantation (composite OR 1.03). and 10% for PPM.
PMH: Known paroxysmal Atrial fib. He is usually is in sinus rhythm as far as he knows, but he cannot subjectively feel atrialfibrillation, so he is never completely certain when he is in sinus or atrial fib. Here is his ECG: Atrial Fib with a Ventricular Response of about 66. He immediately completely recovered.
Arrhythmias, and in particular atrialfibrillation (AF), are one of the greatest healthcare challenges of our time. Arrhythmia prediction models have long relied on conventional riskfactors such as age, diabetes, hypertension, and history of myocardial infarction and heart failure.
AtrialFibrillation (AF) is a heart arrhythmia with influences from lifestyle riskfactors like alcohol use and obesity. As such, patient lifestyles have a prominent role in managing AF.
Objective Atrialfibrillation (AF) remains a highly prevalent arrhythmia with significant burden on morbidity and mortality. AF should be considered in addition to traditional riskfactors for adverse outcomes following revascularisation.
Hypertension is the single most important riskfactor for development of atrialfibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
Heart disease remains one of the leading causes of death worldwide, often attributed to a mix of lifestyle choices, environmental factors, and genetic predispositions. This blog explores how genetics influence heart health and whether mitigating these inherited risks is possible. Can You Prevent Heart Disease if Its in Your Genes?
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 It is not surprising that an enormous increase in cardiovascular riskfactors and diseases will produce a substantial economic burden."
Atrialfibrillation (AF), the most common arrhythmia, has been closely linked to sepsis in prior research. BackgroundSepsis is characterized by high morbidity and mortality rates, alongside limited therapeutic efficacy. However, the specific mechanisms through which sepsis leads to new-onset AF remain poorly understood.
Age is an independent riskfactor for the development of atrialfibrillation (AF). However, how natural aging predisposes to increased AF risk is currently unclear. Investigation prior to overt structural remodeling may therefore be required.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:The strongest genetic riskfactors for atrialfibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor genePITX2.
Abstract Introduction Earlier studies have shown a clear association between severity of human immunodeficiency virus (HIV) infection and incident atrialfibrillation (AF). A total of 31 HIV patients and 31 controls were generated by propensity matching, based on calculated riskfactor scores, using a logistic model.
Low voltage area (LVA) and low conduction velocity (CV) are promising riskfactors to identify patients with abnormal atrial substrate at a high risk of atrialfibrillation (AF) recurrence following pulmonary vein isolation (PVI).
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:An association between sweetened beverages and several cardiometabolic diseases has been reported, but their association with atrialfibrillation (AF) is unclear.
Researchers hypothesized that an AI program trained to analyze echocardiograms might help clinicians detect early, subtle changes in the hearts of patients with undiagnosed arrhythmias. “We Atrialfibrillation can come and go, so it might not be present at a doctor’s appointment. An estimated 12.1
Detection of Irregular Heart Rhythms Devices such as the Apple Watch or Fitbit Sense can detect irregular heart rhythms, including atrialfibrillation (AFib). These early warnings are critical, as AFib increases the risk of stroke and other heart-related complications.
Use of tobacco cigarettes1 and marijuana2 have been associated with a heightened risk of atrialfibrillation (AF) in observational studies. We enrolled individuals that regularly consumed tobacco cigarettes, e-cigarettes, or inhaled marijuana to determine if acute exposure is associated with an increase in ectopy.
The key riskfactor for cardioembolic stroke is atrialfibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias. In patients with diabetes, good glycaemic control can reduce stroke risk.
So, how can you lower your risk for heart attacks, heart disease and other complications? Dr. Schuitema and cardiologist Dr. Daniel Tarditi explain the riskfactors, how to keep the holidays as “heart-friendly” as possible and avoid unnecessary trips to the emergency room.
Complications can occur during each phase, with long-term survivors facing increased risks for late effects such as cardiovascular disease, secondary malignancies, and endocrinopathies. In adults, arrhythmias such as atrialfibrillation and flutter are the most frequent acute cardiovascular complication.
Patients with iCS were more likely to have a history of atrialfibrillation (AF) or hospitalization for heart failure (HF), or lower left ventricular ejection fraction (LVEF) than those with systemic cardiac sarcoidosis. Among 475 patients with CS (mean age, 62.0 ± 10.9 years; During a median follow-up of 42.3 interquartile range, 22.8–72.5)
These complications include new-onset arrhythmias, which are also common in stroke patients who have not experienced heart disease before. For post-stroke patients, arrhythmias represent a key riskfactor for complications and a worse prognosis.
Sleep deprivation or poor sleep can lead to an increased risk of developing conditions such as hypertension, heart disease, stroke, and irregular heart rhythms (arrhythmias). Blood Pressure Regulation Adequate sleep helps regulate blood pressure, a vital factor in heart health.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content